ANI Pharmaceuticals, Inc.NASDAQ: ANIP

ANI Pharmaceuticals to Present at Upcoming December Investor Conference

· Issued by ANI Pharmaceuticals, Inc. via GlobeNewswire

Summary by 6ix AI

ANI Pharmaceuticals President and CEO Nikhil Lalwani and members of the company's executive leadership team will take part in a fireside chat, an interview-style discussion, at the Piper Sandler Healthcare Conference on Tuesday, December 1, 2026 at 12:30 p.m. ET.

Key details

  • The live and archived webcasts will be available on ANI's website, in the Investors section under Events and Presentations.
  • ANI is a diversified biopharmaceutical company with Rare Disease, Generics and Brands businesses.

6ix AI wrote this summary from the release below and checked it against the release.

PRINCETON, N.J., Nov. 19, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team, will participate in a fireside chat at the following upcoming investor conference:

EventPiper Sandler Healthcare Conference
DateTuesday, December 1, 2026
Time12:30 p.m. ET
WebcastClick here

The live and archived webcasts will also be accessible from the Company’s website at www.anipharmaceuticals.com, in the Investors section under Events and Presentations.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit https://www.anipharmaceuticals.com.

Investor Relations:
Irina Koffler, Vice President, Investor Relations
T: 917-734-7387
E: Irina.koffler@anipharmaceuticals.com

Media Relations:
Argot Partners
T: 212-600-1494
E: ani@argotpartners.com

SOURCE: ANI Pharmaceuticals, Inc.

View original source (GlobeNewswire)ANI Pharmaceuticals, Inc. on 6ix

Story so far

Earlier from ANI Pharmaceuticals

All ANI Pharmaceuticals news releases